Hermine Schlagbauer‐Wadl

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

Burkhard Jansen, Hermine Schlagbauer‐Wadl, Bob D. Brown et al. · Nature Medicine · 1998 · 487 citations

Medicine, Oncology, Pharmacology +13

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

Burkhard Jansen, Volker Wacheck, Elisabeth Heere‐Ress et al. · The Lancet · 2000 · 481 citations

Medicine, Cancer Biology, Oncology +14

TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.

Daniela Kandioler-Eckersberger, Christian Ludwig, Margaretha Rudas et al. · PubMed · 2000 · 286 citations

Medicine, Oncology, Pharmacology +14

Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines

Edgar Selzer, Hermine Schlagbauer‐Wadl, Ichiro Okamoto et al. · Melanoma Research · 1998 · 133 citations

Life Sciences, Molecular Biology, Oncology +16

Bcl-2 Antisense Oligonucleotides (G3139) Inhibit Merkel Cell Carcinoma Growth in SCID Mice

Hermine Schlagbauer‐Wadl, Gabriele Klosner, Elisabeth Heere‐Ress et al. · Journal of Investigative Dermatology · 2000 · 99 citations · Full text

Medicine, Molecular Biology, Oncology +13